eMedicine Specialties > Emergency Medicine > Genitourinary
Priapism: Differential Diagnoses & Workup
Updated: Jul 8, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Differential Diagnoses
Other Problems to Be Considered
Peyronie disease
Urethral foreign body
Penile surgical implant
Erection from sexual arousal
Workup
Laboratory Studies
- In patients with no known predisposing factors, a complete blood count (CBC) is appropriate in order to identify the rare case of priapism associated with leukemia.
- Patients with sickle cell disease should have a CBC and a reticulocyte count. If sickle cell status is unknown, a hemoglobin S determination may be useful
- An ABG of the cavernous is useful in differentiating between high and low flow disease. Values similar to venous blood suggest a low-flow etiology. Values similar to arterial blood suggest high-flow priapism.
- Coagulation profile
- Platelet count
- Urinalysis
Imaging Studies
- Color flow penile Doppler imaging is currently the study of choice to differentiate high-flow from low-flow priapism.
- In patients with high-flow priapism, selective penile angiography may be required in order to identify the site of the fistula.
Procedures
- Aspiration/injection of the corpus cavernosum
- First perform a penile nerve block, injecting around the entire base of the penile shaft with 1% lidocaine without epinephrine.
- After anesthesia is ensured, use a 19-gauge needle attached to a large syringe and puncture the corpus cavernosum. This should be performed through the shaft of the penis laterally to avoid the corpus spongiosum and urethra ventrally and the neurovascular bundle dorsally.
- Aspirate 20-30 mL of blood from either the 2-o'clock or 10-o'clock position while milking the shaft. Because multiple communications exist from one corpus to the other, aspiration usually is required only on one side.
- If aspiration or injection is successful in producing detumescence, place an elastic bandage around the shaft of the penis to ensure continued emptying of the corpora and to compress the puncture site.
- Aspiration alone has a success rate of around 30%. If this procedure is not successful, phenylephrine, epinephrine, or methylene blue may be instilled into the corpus cavernosa.
More on Priapism |
| Overview: Priapism |
Differential Diagnoses & Workup: Priapism |
| Treatment & Medication: Priapism |
| Follow-up: Priapism |
| References |
| « Previous Page | Next Page » |
References
Bastuba MD, Saenz de Tejada I, Dinlenc CZ, et al. Arterial priapism: diagnosis, treatment and long-term followup. J Urol. May 1994;151(5):1231-7. [Medline].
Brock G, Breza J, Lue TF, Tanagho EA. High flow priapism: a spectrum of disease. J Urol. Sep 1993;150(3):968-71. [Medline].
Cherian J, Rao AR, Thwaini A, et al. Medical and surgical management of priapism. Postgrad Med J. Feb 2006;82(964):89-94. [Medline].
Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. May 2001;57(5):970-2. [Medline].
Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. Nov 1980;140(11):1434-7. [Medline].
Foda MM, Mahmood K, Rasuli P, Dunlap H, Kiruluta G, Schillinger JF. High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature. Urology. Dec 1996;48(6):949-52. [Medline].
Harmon WJ, Nehra A. Priapism: diagnosis and management. Mayo Clin Proc. Apr 1997;72(4):350-5. [Medline].
Hatzichristou D, Salpiggidis G, Hatzimouratidis K, et al. Management strategy for arterial priapism: therapeutic dilemmas. J Urol. Nov 2002;168(5):2074-7. [Medline].
Ilkay AK, Levine LA. Conservative management of high-flow priapism. Urology. Sep 1995;46(3):419-24. [Medline].
Jiva T, Anwer S. Priapism associated with chronic cocaine abuse. Arch Intern Med. Aug 8 1994;154(15):1770. [Medline].
Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J Urol. Apr 1995;153(4):1182-3. [Medline].
Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. Jul 1993;42(1):51-3; discussion 53-4. [Medline].
Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, et al, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders Co; 1997:1157-79.
Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol. Aug 1995;154(2 Pt 2):844-7. [Medline].
Mulhall JP, Honig SC. Priapism: etiology and management. Acad Emerg Med. Aug 1996;3(8):810-6. [Medline].
Ramos CE, Park JS, Ritchey ML, Benson GS. High flow priapism associated with sickle cell disease. J Urol. May 1995;153(5):1619-21. [Medline].
Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol. Nov 1993;150(5 Pt 1):1480-2. [Medline].
Further Reading
Keywords
priapus, corpora cavernosa, arterial high-flow priapism, veno-occlusive priapism, painful erection of the penis, sickle cell disease, impotence, papaverine use, phentolamine use, prostaglandin E1 use, citalopram, androstenedione, leukemia, thalassemia, multiple myeloma, tumor infiltration, spinal cord injury, spinal anesthesia, Fabry disease, recent infection with mycoplasma pneumonia, amyloidosis, carbon monoxide poisoning, malaria, black widow spider bites, cocaine abuse, marijuana abuse, ethanol abuse
Differential Diagnoses & Workup: Priapism